Equities analysts expect Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) to announce earnings of $0.17 per share for the current quarter, Zacks reports. Ten analysts have provided estimates for Allscripts Healthcare Solutions’ earnings. The highest EPS estimate is $0.19 and the lowest is $0.13. Allscripts Healthcare Solutions posted earnings per share of $0.18 during the same quarter last year, which suggests a negative year over year growth rate of 5.6%. The company is expected to issue its next quarterly earnings report on Thursday, November 7th.

On average, analysts expect that Allscripts Healthcare Solutions will report full-year earnings of $0.68 per share for the current financial year, with EPS estimates ranging from $0.66 to $0.71. For the next year, analysts forecast that the business will report earnings of $0.77 per share, with EPS estimates ranging from $0.72 to $0.83. Zacks’ earnings per share averages are a mean average based on a survey of analysts that that provide coverage for Allscripts Healthcare Solutions.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its earnings results on Thursday, August 8th. The software maker reported $0.17 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.16 by $0.01. The firm had revenue of $444.50 million during the quarter, compared to analysts’ expectations of $449.03 million. Allscripts Healthcare Solutions had a net margin of 9.85% and a return on equity of 6.17%. Allscripts Healthcare Solutions’s revenue for the quarter was up .7% on a year-over-year basis. During the same period in the previous year, the company earned $0.18 EPS.

Several equities analysts recently weighed in on the stock. Jefferies Financial Group assumed coverage on shares of Allscripts Healthcare Solutions in a report on Friday, August 23rd. They set a “buy” rating and a $13.00 target price on the stock. TheStreet upgraded shares of Allscripts Healthcare Solutions from a “d+” rating to a “c-” rating in a report on Friday, September 20th. ValuEngine upgraded shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a report on Monday, September 30th. Evercore ISI restated a “hold” rating and set a $11.50 target price on shares of Allscripts Healthcare Solutions in a report on Sunday, August 11th. Finally, BidaskClub upgraded shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a report on Tuesday, September 24th. Ten research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Allscripts Healthcare Solutions has a consensus rating of “Hold” and an average price target of $12.19.

A number of institutional investors have recently added to or reduced their stakes in the stock. Glen Harbor Capital Management LLC increased its stake in Allscripts Healthcare Solutions by 7.7% during the 2nd quarter. Glen Harbor Capital Management LLC now owns 17,504 shares of the software maker’s stock worth $204,000 after buying an additional 1,248 shares during the period. Tyers Asset Management LLC increased its stake in Allscripts Healthcare Solutions by 7.7% during the 2nd quarter. Tyers Asset Management LLC now owns 24,068 shares of the software maker’s stock worth $280,000 after buying an additional 1,716 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Allscripts Healthcare Solutions by 16.9% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,460 shares of the software maker’s stock worth $145,000 after buying an additional 1,800 shares during the period. Riverhead Capital Management LLC increased its stake in Allscripts Healthcare Solutions by 7.5% during the 2nd quarter. Riverhead Capital Management LLC now owns 27,330 shares of the software maker’s stock worth $318,000 after buying an additional 1,900 shares during the period. Finally, Flinton Capital Management LLC increased its stake in Allscripts Healthcare Solutions by 7.7% during the 2nd quarter. Flinton Capital Management LLC now owns 30,632 shares of the software maker’s stock worth $356,000 after buying an additional 2,184 shares during the period.

Shares of NASDAQ:MDRX traded up $0.29 during midday trading on Wednesday, hitting $10.81. 2,180,503 shares of the company’s stock traded hands, compared to its average volume of 1,959,446. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.91 and a current ratio of 0.91. The company has a market cap of $1.80 billion, a PE ratio of 19.65, a P/E/G ratio of 2.44 and a beta of 1.39. The firm’s fifty day moving average price is $10.15 and its two-hundred day moving average price is $10.22. Allscripts Healthcare Solutions has a twelve month low of $8.54 and a twelve month high of $14.11.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.

Featured Story: Market Perform

Get a free copy of the Zacks research report on Allscripts Healthcare Solutions (MDRX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.